Articular Cartilage
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Cell Therapy
2100%
Competitive Landscape
1 companies ranked by most advanced pipeline stage
VericelCAMBRIDGE, MA
2 programsCarticelN/ACell Therapy1 trial
CarticelPHASE_4Cell Therapy1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
VericelCarticel
VericelCarticel
Clinical Trials (2)
Total enrollment: 2,359 patients across 2 trials
Study of the Treatment of Articular Repair (STAR)
Start: Mar 2000Est. completion: Nov 2005126 patients
Phase 4Completed
The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry Patients
Start: Mar 1995Est. completion: Jan 20092,233 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.